Eran Leitersdorf
Eran Leitersdorf
Professor of Medicine Hebrew University Hadassah Medical School
Dirección de correo verificada de
Citado por
Citado por
Effects of dalcetrapib in patients with a recent acute coronary syndrome
GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ...
New England Journal of Medicine 367 (22), 2089-2099, 2012
Mechanism of action of fibrates on lipid and lipoprotein metabolism
B Staels, J Dallongeville, J Auwerx, K Schoonjans, E Leitersdorf, ...
Circulation 98 (19), 2088-2093, 1998
Atherosclerosis in the apolipoprotein E–deficient mouse: a decade of progress
KS Meir, E Leitersdorf
Arteriosclerosis, thrombosis, and vascular biology 24 (6), 1006-1014, 2004
Risk for myopathy with statin therapy in high-risk patients
CM Ballantyne, A Corsini, MH Davidson, H Holdaas, TA Jacobson, ...
Archives of internal medicine 163 (5), 553-564, 2003
Common low-density lipoprotein receptor mutations in the French Canadian population.
E Leitersdorf, EJ Tobin, J Davignon, HH Hobbs
The Journal of clinical investigation 85 (4), 1014-1023, 1990
Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism: comparison with high density lipoprotein-mediated reverse cholesterol …
A Babiker, O Andersson, E Lund, RJ Xiu, S Deeb, A Reshef, E Leitersdorf, ...
Journal of Biological Chemistry 272 (42), 26253-26261, 1997
Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease. Fibrate Consensus Group.
JC Fruchart, HB Brewer Jr, E Leitersdorf
The American journal of cardiology 81 (7), 912-917, 1998
Markedly reduced bile acid synthesis but maintained levels of cholesterol and vitamin D metabolites in mice with disrupted sterol 27-hydroxylase gene
H Rosen, A Reshef, N Maeda, A Lippoldt, S Shpizen, L Triger, ...
Journal of Biological Chemistry 273 (24), 14805-14812, 1998
Possible association between diabetes and bisphosphonate-related jaw osteonecrosis
M Khamaisi, E Regev, N Yarom, B Avni, E Leitersdorf, I Raz, S Elad
The Journal of Clinical Endocrinology & Metabolism 92 (3), 1172-1175, 2007
Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners.
E Leitersdorf, DR Van der Westhuyzen, GA Coetzee, HH Hobbs
The Journal of clinical investigation 84 (3), 954-961, 1989
Identification of bile acid precursors as endogenous ligands for the nuclear xenobiotic pregnane X receptor
B Goodwin, KC Gauthier, M Umetani, MA Watson, MI Lochansky, ...
Proceedings of the National Academy of Sciences 100 (1), 223-228, 2003
Rationale and design of the dal-OUTCOMES trial: efficacy and safety of dalcetrapib in patients with recent acute coronary syndrome
GG Schwartz, AG Olsson, CM Ballantyne, PJ Barter, IM Holme, D Kallend, ...
American heart journal 158 (6), 896-901. e3, 2009
Disruption of the sterol 27-hydroxylase gene in mice results in hepatomegaly and hypertriglyceridemia: reversal by cholic acid feeding
JJ Repa, EG Lund, JD Horton, E Leitersdorf, DW Russell, JM Dietschy, ...
Journal of Biological Chemistry 275 (50), 39685-39692, 2000
A truncated human peroxisome proliferator-activated receptor α splice variant with dominant negative activity
P Gervois, IP Torra, G Chinetti, T Grötzinger, G Dubois, JC Fruchart, ...
Molecular Endocrinology 13 (9), 1535-1549, 1999
Frameshift and splice-junction mutations in the sterol 27-hydroxylase gene cause cerebrotendinous xanthomatosis in Jews or Moroccan origin.
E Leitersdorf, A Reshef, V Meiner, R Levitzki, SP Schwartz, EJ Dann, ...
The Journal of clinical investigation 91 (6), 2488-2496, 1993
Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells
T Nassar, BS Sachais, S Akkawi, MA Kowalska, K Bdeir, E Leitersdorf, ...
Journal of Biological Chemistry 278 (8), 6187-6193, 2003
Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defective low density lipoprotein receptors.
HH Hobbs, E Leitersdorf, CC Leffert, DR Cryer, MS Brown, JL Goldstein
The Journal of clinical investigation 84 (2), 656-664, 1989
Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in …
M Futema, S Shah, JA Cooper, KW Li, RA Whittall, M Sharifi, O Goldberg, ...
Clinical chemistry 61 (1), 231-238, 2015
Effects of initiating moderate alcohol intake on cardiometabolic risk in adults with type 2 diabetes: a 2-year randomized, controlled trial
Y Gepner, R Golan, I Harman-Boehm, Y Henkin, D Schwarzfuchs, I Shelef, ...
Annals of internal medicine 163 (8), 569-579, 2015
Alcohol dehydrogenase polymorphisms influence alcohol‐elimination rates in a male Jewish population
YD Neumark, Y Friedlander, R Durst, E Leitersdorf, D Jaffe, ...
Alcoholism: Clinical and Experimental Research 28 (1), 10-14, 2004
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20